56P-24983-04601
2 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 085 / NJ
- Registered
- 2021-08-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-10
Dose 1 — Pfizer-BioNTech
-
2021-08-12
Registered in v-safe
- 2021-08-12
- 2021-08-14
- 2021-08-15
- 2021-08-24
-
2021-08-31
Dose 2 — Pfizer-BioNTech
-
2021-09-01
Survey response — days 1–6 daily, dose 2MedDRA: Pyrexia — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: FeverMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-10 | Pfizer-BioNTech | No |
| 2 | 2021-08-31 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Pyrexia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release